The STEP 1 trial, published in the New England Journal of Medicine, demonstrated 14.9 percent mean body weight reduction with the 2.4mg weekly dose over 68 weeks, compared to just 2.4 percent with placebo
Availability depends on medical history, clinical eligibility, patient location, doctor licensure, pharmacy capabilities, applicable federal and state law, and future FDA action
Lyophilised format: Freeze-dried powder is the only appropriate format for research-grade stability during transit and long-term storage
Preparation Wash hands thoroughly with soap and water
The acquired images were analyzed using an optimized pipeline for each cell line on Harmony v.4.9 high-content analysis software (PerkinElmer)
Most protocols run 8-12 weeks, followed by 4-8 weeks off